FDA approves Cialis to treat benign prostatic hyperplasia

Posted by Food and Drug Administration--Press Releases on Thursday Oct 6, 2011 Under Uncategorized

The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of ED.

Be Sociable, Share!

Comments are closed.